Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients

Elimination of a rifamycin from the treatment regimen for tuberculosis negatively impacts outcomes. Cross-reactivity between the rifamycins after drug eruptions is unclear. We report 6 consecutive human immunodeficiency virus-infected patients with rifampicin-associated drug rash with eosinophilia a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Lehloenya, Rannakoe J., Dlamini, Sipho, Muloiwa, Rudzani, Kakande, Betty, Ngwanya, Mzudumile R., Todd, Gail, Dheda, Keertan
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2016
Témata:
Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4942758/
https://ncbi.nlm.nih.gov/pubmed/27419190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw130
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky